Lanreotide

Spezifikationen

108736-35-2CAS-Nummer

689-178-4EG-Nummer

(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2R)-2-amino-3-naphthalen-2-ylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pIUPAC-Name

C54H69N11O10S2Chemische Formel

1096.3 g/molMolekulargewicht

Lanreotide; 108736-35-2; Ipstyl; Lanreotida; Lanreotidum; Lanreotide Autogel; BIM 23014; Bim-23014; DC 13-116; Nal-cyclo(cys-tyr-trp-lys-val-cys)-thr-NH2; DTXSID60897514; 0G3DE8943Y; Somatulina; Somatuline LA; L-Threoninamide, 3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2-7)-disulfide; BIM 23014C; DC13-116; Dermopeptin; RefChem:56442; H01CB03; DTXCID601326869; DC 13116; DC-13-116; Nal-cyclo(Cys-Tyr-Trp-Lys-Val-Cys)Thr-NH2; naphthyl-cyclo(Cys-Tyr-Trp-Lys-Val-Cys)Thr-NH2; 2-naphthylalanyl-cyclo(cysteinyl-tyrosyl-tryptophyl-lysyl-valyl-cysteinyl)-threoninamide; naphthalenyl-cyclo(cysteinyl-tyrosyl-tryptophyl-lysyl-valyl-cysteinyl)threoninamide; L-Threoninamide, 3-(1-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2-7)-disulfide; 10-(4-aminobutyl)-N-(1-amino-3-hydroxy-1-oxobutan-2-yl)-19-((2-amino-3-naphthalen-2-ylpropanoyl)amino)-16-((4-hydroxyphenyl)methyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide; 3-(2-Naphthyl)-D-ala-cys-tyr-D-trp-lys-val-cys-thr-NH2; 3-(2-Naphthyl)alanyl-cystinyl-tyrosyl-tryptophyl-lysyl-valyl-cystinyl-threonine amide; BIM-23014 C; D-Nal-cys-tyr-trp-lys-val-cys-thr-NH2; 118992-92-0; (4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-19-[[(2R)-2-amino-3-naphthalen-2-ylpropanoyl]amino]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide; (4R,7S,10S,13R,16S,19R)-13-((1H-indol-3-yl)methyl)-19-((R)-2-amino-3-(naphthalen-2-yl)propanamido)-N-((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)-10-(4-aminobutyl)-16-(4-hydroxybenzyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide; L-Threoninamide, 3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2-->7)-disulfide; C54H69N11O10S2; Autogel; Somatulin; Somatulin-Autogel; Lanreotide [INN:BAN]; Lanreotidum [INN-Latin]; Lanreotida [INN-Spanish]; UNII-0G3DE8943Y; 188Re-lanreotide; 108736-35-2 (free base); Lanreotide,Lanreotide Acetate; orb1705579; 108736-35-2free base; CHEMBL1201185; SCHEMBL29356077; SCHEMBL29402091; SCHEMBL29450601; BDBM82470; HY-P1959; MFCD03424071; AKOS030573447; AC-38405; BP-43730; BP-43731; FL110376; CS-0103335; NS00005999; C71317; Q1707877; 3-(2-Naphtyl)-D-Ala-L-Cys(1)-L-Tyr-D-Trp-L-Lys-L-Val-L-Cys(1)-L-Thr-NH2; (4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-19-[[(2R)-2-amino-3-(2-naphthyl)propanoyl]amino]-N-[(1S,2R)-1-carbamoyl-2-hydroxy-propyl]-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol-3-ylmethyl)-7-isopropyl-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide; (4R,7S,10S,13R,16S,19R)-10-(4-Aminobutyl)-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]-16-[(4-hydroxyphenyl)methyl]-13-[(1H-indol-3-yl)methyl]-19-{[3-(naphthalen-2-yl)-D-alanyl]amino}-6,9,12,15,18-pentaoxo-7-(propan-2-yl)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide; L-Threoninamide, 3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2 inverted exclamation marku7)-disulfideSynonyme